Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 5.298\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC(=O)c1ccc(-c2nnc(CCC(=O)N(C)Cc3c(C)nc4ccccn34)o2)s1
b. CCc1cccc(NC(=O)CSCc2nc3sc(C)c(C)c3c(=O)[nH]2)c1
Answer: a. CC(=O)c1ccc(-c2nnc(CCC(=O)N(C)Cc3c(C)nc4ccccn34)o2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)c1ccc(-c2nnc(CCC(=O)N(C)Cc3c(C)nc4ccccn34)o2)s1
CC(=O)c1ccc(-c2nnc(CCC(=O)N(C)Cc3c(C)nc4ccccn34)o2)s1
3-[5-(5-acetylthiophen-2-yl)-1,3,4-oxadiazol-2-yl]-N-methyl-N-[(2-methylimidazo[1,2-a]pyridin-3-yl)methyl]propanamide